Subject: Fwd: Letter from Drs. Collins and Woodcock
From: Tamar Gabunia <[email-masked]>
To: info <[email-masked]>, Maia Nikoleishvili <[email-masked]>
Date: Thu, 01 Oct 2020 20:10:57 +0000

გთხოვთ დაარეგისტრიროთ

Get Outlook for Android

From: Lane, Cliff (NIH/NIAID) [E]

Sent: Friday, October 2, 2020, 00:04

To: [email-masked]

Cc: [email-masked]; Jens Lundgren; [email-masked]

Subject: Letter from Drs. Collins and Woodcock

Dear Dr. Tikaradze,

Please see the attached letters from the NIH Director and the Therapeutics Lead for the Operation Warp Speed initiative of the US government.  We appreciate the efforts of the
investigators in Georgia to get the ACTIV-3 study.  This is a global trial sponsored by the NIH.

Sincerely,

H. Clifford Lane, M.D.

Deputy Director for Clinical Research and Special Projects

National Institute of Allergy and Infectious Diseases

National Institutes of Health